Conference Coverage

Culotte stenting impresses in CELTIC Bifurcation Study


 

REPORTING FROM EUROPCR 2018


“Many of us use the DK [double kissing] crush technique,” another panelist said. “It’s very popular. But if you look at bench testing, perhaps culotte is a better approach by many parameters. So I think it was important for you to highlight the value of culotte and how it can be done properly.”

Discussant James Nolan, MD, a cardiologist at the University Hospital of North Staffordshire (England), said, “The most critical thing with these bifurcation procedures is the operators and how they do it. So you have to do the culotte to the standard done in this trial. If you do a sloppy culotte, it’s not going to be great. It’s probably more important to deliver an excellently performed procedure, whatever it is. You’ll get a better result if you’re good at what you’re doing rather than selecting one procedure or another.”

Dr. Foley agreed, adding: “In some of the DK crush versus culotte randomized trials, I’m not convinced that culotte was done the way I would suggest it should be done.”

Operators in the CELTIC Bifurcation Study were asked to follow a standardized culotte procedure: predilate both limbs of the bifurcation, keep both wires in place, deploy the first stent in the side branch unless the main branch was awkwardly angulated, then cross by going from distally into the optimized first stent, and placing the second stent proximal to the first stent so that the two stents overlap in the proximal main vessel.

“We call that ‘nailing it down,’ ” he explained.

The procedure is completed by sequential high-pressure kissing balloon dilatation of both branches, with intravascular ultrasound or optical coherence tomography recommended but not required.

Simultaneously with this presentation, the study results were published online (EuroIntervention 2018 Jun 8;14[3]:e318-24).

The CELTIC Bifurcation Study was funded by an unrestricted grant from Boston Scientific. Dr. Foley reported having no financial conflicts of interest regarding the study.

Pages

Recommended Reading

Serum troponin predicts cardiovascular death in early arthritis
MDedge Cardiology
Better stent technology needed for diabetes patients
MDedge Cardiology
Alirocumab’s benefit greater in diabetes patients: ODYSSEY Outcomes
MDedge Cardiology
New look at ATLAS suggests rivaroxaban may still have role in ACS
MDedge Cardiology
DOJ lawsuit reins in inappropriate ICD use
MDedge Cardiology
Alteplase, aspirin provide similar functional outcomes after nondisabling stroke
MDedge Cardiology
Obesity triples post-MI sudden cardiac death risk
MDedge Cardiology
Older black patients die sooner after in-hospital cardiac arrest
MDedge Cardiology
Medicare’s bundled pay plan didn’t deliver big cost savings
MDedge Cardiology
Epinephrine for cardiac arrest: Better survival, more brain damage
MDedge Cardiology